findmyKOL
Clinical trialNCT03960606TerminatedPhase 2Interventional

Study in Adult Asthmatic Patients With Allergic Bronchopulmonary Aspergillosis

SponsorPulmatrix Inc.Enrollment7Allergic Bronchopulmonary Aspergillosis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • David Denning, FRCP, FRC Path, FIDSA, FMedSci

    Director, National Aspergillosis Centre Manchester, Wythenshawe M23 9LT, UK

    Principal Investigator
  • William J. Calhoun, MD

    University of Texas Medical Branch Galveston, TX 77555

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • John Hunter Hospital

    New Lambton, New South Wales, Australia

  • Mater Private Hospital Brisbane

    Brisbane, Queensland, Australia

India
  • Yashoda Hospital

    Hyderabad, Andhra Pradesh, India

  • Shree Hospital and Critical Care Centre

    Nagpur, Maharashtra, India

  • Sms Medical College and Hospital

    Jaipur, Rajasthan, India

Poland
  • Centrum Alergologii Teresa Hofman

    Poznan, Greater Poland Voivodeship, Poland

  • Centrum Medycyny Oddechowej Mroz Sp. J.

    Bialystok, Podlaskie Voivodeship, Poland

  • Uniwersyteckie Centrum Kliniczne - Ppds

    Gdansk, Pomeranian Voivodeship, Poland

  • Pulmag Arkadiusz Brodowski, Grzegorz Gasior S. C.

    Sosnowiec, Silesian Voivodeship, Poland

United Kingdom
  • Birmingham Heartlands Hospital

    Birmingham, West Midlands, United Kingdom

  • Wythenshawe Hospital - Ppds

    Manchester, United Kingdom

United States
  • National Jewish Health

    Denver, Colorado, United States

  • Yale University School of Medicine

    New Haven, Connecticut, United States

  • Integrity Clinical Research Center Inc.

    Hialeah, Florida, United States

  • Heuer M.D Research Inc.

    Miami Lakes, Florida, United States

  • Infinite Clinical Trials

    Roswell, Georgia, United States

  • University Consultants in Allergy and Immunology

    Chicago, Illinois, United States

  • Laporte County Institute for Clinical Research

    Michigan City, Indiana, United States

  • Montefiore Medical Center

    The Bronx, New York, United States

  • University of Texas Medical Branch at Galveston

    Galveston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jul 2019
Primary completion
14 Jul 2020
Completion
14 Jul 2020
Last update posted
27 Aug 2021
Registered enrollment
7
Registry id
NCT03960606

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.